Compounds > deferoxamine

deferoxamine and desferrithiocin

deferoxamine has been researched along with desferrithiocin in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (45.45)	18.7374
1990's	5 (45.45)	18.2507
2000's	1 (9.09)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, E; Jacobs, A; Peter, H; Wong, A	1
Cook, EP; Fragonas, JC; Hunt, NH	1
Bergeron, RJ; Evans, KM; Jenny, HB; Luchetta, G; Peter, H; Streiff, RR; Vinson, JR; Wiegand, J	1
Bierer, BE; Nathan, DG	1
Chaudhri, G; Clark, IA	1
Finger, J; Hegsted, M; Nathan, DG; Nicolosi, RJ; Peter, H; Renaud, MM; Wolfe, LC	1
Baquet, A; Crichton, RR; Florence, A; Jin, Y; Schneider, YJ	1
Beaudoin, RL; Gentilini, M; Guillouzo, A; Landau, I; Langlois, P; Mazier, D; Mellouk, S; Miltgen, F; Stahel, E	1
Crichton, RR; Longueville, A	1
Bergeron, RJ; Creary, EA; Daniels, RD; King, W; Luchetta, G; Moerker, T; Peter, HH; Streiff, RR; Wiegand, J	1
Baker, E; Chua, AC; Kicic, A	1

Other Studies

11 other study(ies) available for deferoxamine and desferrithiocin

Article	Year
Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic. British journal of haematology, 1992, Volume: 81, Issue:3 Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Cells, Cultured; Deferoxamine; Dihydropyridines; Dose-Response Relationship, Drug; Injections, Subcutaneous; Iodine Radioisotopes; Iron; Iron Chelating Agents; Iron Radioisotopes; Liver; Rats; Rats, Wistar; Thiazoles; Time Factors; Transferrin; Weight Gain	1992
Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytes. International journal of immunopharmacology, 1991, Volume: 13, Issue:7 Topics: Animals; B-Lymphocytes; Deferoxamine; Dihydropyridines; DNA; Ferricyanides; Humans; In Vitro Techniques; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxygen; T-Lymphocytes; Thiazoles	1991
A comparative evaluation of iron clearance models. Annals of the New York Academy of Sciences, 1990, Volume: 612 Topics: Animals; Bile; Chelating Agents; Deferoxamine; Dihydropyridines; Haplorhini; Hydrazines; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Spectrophotometry, Atomic; Thiazoles	1990
The effect of desferrithiocin, an oral iron chelator, on T-cell function. Blood, 1990, Nov-15, Volume: 76, Issue:10 Topics: Antigens, Surface; Calcium; Cell Division; Cell Membrane; Cells, Cultured; Cytotoxicity, Immunologic; Deferoxamine; Dihydropyridines; Humans; Interleukin-2; Iron; Iron Chelating Agents; Killer Cells, Natural; Lymphocyte Activation; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Thiazoles	1990
Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. Journal of immunology (Baltimore, Md. : 1950), 1989, Aug-15, Volume: 143, Issue:4 Topics: Animals; Antioxidants; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Deferoxamine; Dihydropyridines; Free Radicals; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred CBA; Oxygen; Peritoneal Cavity; Thiazoles; Tumor Necrosis Factor-alpha	1989
A non-human primate model for the study of oral iron chelators. British journal of haematology, 1989, Volume: 72, Issue:3 Topics: Administration, Oral; Animals; Cebus; Deferoxamine; Dihydropyridines; Disease Models, Animal; Injections, Intramuscular; Iron; Iron Chelating Agents; Thiazoles	1989
Desferrithiocin and desferrioxamine B. Cellular pharmacology and storage iron mobilization. Biochemical pharmacology, 1989, Oct-01, Volume: 38, Issue:19 Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Iron; Liver; Male; Rats; Rats, Inbred Strains; Thiazoles; Tritium	1989
Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria. The American journal of tropical medicine and hygiene, 1988, Volume: 39, Issue:3 Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Humans; Iron Chelating Agents; Liver; Malaria; Microscopy, Electron; Plasmodium falciparum; Plasmodium yoelii; Rats; Thiazoles	1988
An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators. Biochemical pharmacology, 1986, Nov-01, Volume: 35, Issue:21 Topics: Administration, Oral; Animals; Body Weight; Chelating Agents; Deferoxamine; Dihydropyridines; Ferritins; Ferrous Compounds; Injections, Intraperitoneal; Liver; Male; Metallocenes; Organ Size; Organometallic Compounds; Pyridines; Rats; Rats, Inbred Strains; Thiazoles	1986
A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model. Blood, 1993, Apr-15, Volume: 81, Issue:8 Topics: Animals; Cebus; Deferoxamine; Dihydropyridines; Feces; Gastrointestinal Diseases; Iron; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Siderophores; Thiazoles	1993
Desferrithiocin is a more potent antineoplastic agent than desferrioxamine. British journal of pharmacology, 2002, Volume: 135, Issue:6 Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Deferoxamine; Dihydropyridines; Fibroblasts; Hepatocytes; Humans; Iron; Iron Chelating Agents; Male; Mice; Rats; Rats, Wistar; Thiazoles; Tumor Cells, Cultured	2002